Challenges to FDA's ability to monitor and inspect foreign clinical trials.
- Physical Description: 1 online resource (iv, 43 pages) : illustrations, color map
- Publisher: [Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2010.
|General Note:|| Title from title screen (viewed Aug 9, 2016).
|Bibliography, etc. Note:|| Includes bibliographical references.
Search for related items by subject
|Subject:||Clinical trials > Government policy > United States.
Biologicals > United States > Testing > Government policy.
Drugs > United States > Testing > Government policy.
United States. Food and Drug Administration > Auditing.